Published in Clin Microbiol Rev on April 01, 2011
Diagnostic point-of-care tests in resource-limited settings. Lancet Infect Dis (2013) 3.56
The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLoS One (2012) 2.88
Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLoS Med (2012) 2.54
Opportunities and challenges for cost-efficient implementation of new point-of-care diagnostics for HIV and tuberculosis. J Infect Dis (2012) 1.82
Use of a molecular diagnostic test in AFB smear positive tuberculosis suspects greatly reduces time to detection of multidrug resistant tuberculosis. PLoS One (2012) 1.76
First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistances. J Clin Microbiol (2012) 1.41
Dried culture spots for Xpert MTB/RIF external quality assessment: results of a phase 1 pilot study in South Africa. J Clin Microbiol (2011) 1.33
Perspectives on introduction and implementation of new point-of-care diagnostic tests. J Infect Dis (2012) 1.33
Nucleic acid testing for tuberculosis at the point-of-care in high-burden countries. Expert Rev Mol Diagn (2012) 1.24
Rapid Diagnosis of Pulmonary and Extrapulmonary Tuberculosis in HIV-Infected Patients. Comparison of LED Fluorescent Microscopy and the GeneXpert MTB/RIF Assay in a District Hospital in India. Tuberc Res Treat (2012) 1.23
Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments. PLoS One (2012) 1.15
Significant clinical impact of a rapid molecular diagnostic test (Genotype MTBDRplus assay) to detect multidrug-resistant tuberculosis. Clin Infect Dis (2014) 1.14
Target product profile of a molecular drug-susceptibility test for use in microscopy centers. J Infect Dis (2015) 1.08
Molecular characterization of multidrug- and extensively drug-resistant Mycobacterium tuberculosis strains in Jiangxi, China. J Clin Microbiol (2012) 1.06
Point-of-care assays for tuberculosis: role of nanotechnology/microfluidics. Biotechnol Adv (2013) 1.06
Clinical research and development of tuberculosis diagnostics: moving from silos to synergy. J Infect Dis (2012) 1.03
"Multidrug-resistant tuberculosis" may be nontuberculous mycobacteria. Eur J Intern Med (2015) 1.02
Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium. Indian J Med Res (2013) 1.01
Field evaluation of the Cepheid GeneXpert Chlamydia trachomatis assay for detection of infection in a trachoma endemic community in Tanzania. PLoS Negl Trop Dis (2013) 0.96
Multicenter feasibility study to assess external quality assessment panels for Xpert MTB/RIF assay in South Africa. J Clin Microbiol (2014) 0.95
PEPFAR support for the scaling up of collaborative TB/HIV activities. J Acquir Immune Defic Syndr (2012) 0.95
Infections Caused by Mycobacterium tuberculosis in Recipients of Hematopoietic Stem Cell Transplantation. Front Oncol (2014) 0.91
Opportunities for improved serodiagnosis of human tuberculosis, bovine tuberculosis, and paratuberculosis. Vet Med Int (2012) 0.91
Performance of the MTBDRsl assay in Georgia. Int J Tuberc Lung Dis (2014) 0.90
Point-of-care system for detection of Mycobacterium tuberculosis and rifampin resistance in sputum samples. J Clin Microbiol (2013) 0.88
Leishmaniasis in the middle East: incidence and epidemiology. PLoS Negl Trop Dis (2014) 0.86
A Clinical Scoring Algorithm for Determination of the Risk of Tuberculosis in HIV-Infected Adults: A Cohort Study Performed at Ethiopian Health Centers. Open Forum Infect Dis (2014) 0.86
Application of a microcalorimetric method for determining drug susceptibility in mycobacterium species. J Clin Microbiol (2011) 0.84
Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosis. PLoS One (2013) 0.84
Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB. PLoS One (2016) 0.84
Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China. BMC Infect Dis (2013) 0.82
Utility of Line Probe Assay for the Early Detection of Multidrug-Resistant Pulmonary Tuberculosis. J Glob Infect Dis (2015) 0.81
Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables. Int J Mycobacteriol (2015) 0.80
Assigning focal persons to notify more tuberculosis patients: lessons learned in southern Ethiopia. Public Health Action (2014) 0.80
FN-Identify: Novel Restriction Enzymes-Based Method for Bacterial Identification in Absence of Genome Sequencing. Adv Bioinformatics (2015) 0.80
Development and clinical evaluation of sdaA loop-mediated isothermal amplification assay for detection of Mycobacterium tuberculosis with an approach to prevent carryover contamination. J Clin Microbiol (2014) 0.80
Total Delay Is Associated with Unfavorable Treatment Outcome among Pulmonary Tuberculosis Patients in West Gojjam Zone, Northwest Ethiopia: A Prospective Cohort Study. PLoS One (2016) 0.80
One nanoprobe, two pathogens: gold nanoprobes multiplexing for point-of-care. J Nanobiotechnology (2015) 0.80
Paraspinal abscess secondary to tuberculous spondylitis diagnosed by Xpert MTB/RIF assay in rural Tanzania. BMJ Case Rep (2013) 0.79
New directions using reporter enzyme fluorescence (REF) as a tuberculosis diagnostic platform. Tuberculosis (Edinb) (2016) 0.79
Diagnosis of mycobacterial infections based on acid-fast bacilli test and bacterial growth time and implications on treatment and disease outcome. BMC Infect Dis (2016) 0.79
Feasibility of establishing a biosafety level 3 tuberculosis culture laboratory of acceptable quality standards in a resource-limited setting: an experience from Uganda. Health Res Policy Syst (2015) 0.79
Qualitative Assessment of Challenges in Tuberculosis Control in West Gojjam Zone, Northwest Ethiopia: Health Workers' and Tuberculosis Control Program Coordinators' Perspectives. Tuberc Res Treat (2016) 0.79
Patients' and health system's delays in the diagnosis and treatment of new pulmonary tuberculosis patients in West Gojjam Zone, Northwest Ethiopia: a cross-sectional study. BMC Infect Dis (2016) 0.78
Implementation of MALDI-TOF MS technology for the identification of clinical isolates of Mycobacterium spp. in mycobacterial diagnosis. Eur J Clin Microbiol Infect Dis (2015) 0.78
Semi-automated, occupationally safe immunofluorescence microtip sensor for rapid detection of Mycobacterium cells in sputum. PLoS One (2014) 0.78
Emergence in Western African countries of MDR-TB, focus on Côte d'Ivoire. Biomed Res Int (2013) 0.78
Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis. Emerg Infect Dis (2015) 0.78
The Application of GeneXpert MTB/RIF for Smear-Negative TB Diagnosis as a Fee-Paying Service at a South Asian General Hospital. Tuberc Res Treat (2015) 0.78
Macrocolonies (Granules) Formation as a Cause of False-Negative Results in the MGIT 960 System: Cause Analysis and Correlation with Mycobacterial Species. Biomed Res Int (2015) 0.77
The quality of sputum smear microscopy in public-private mix directly observed treatment laboratories in West Amhara region, Ethiopia. PLoS One (2015) 0.76
A pilot evaluation of external quality assessment of GenoType MTBDRplus versions 1 and 2 using dried culture spot material. J Clin Microbiol (2015) 0.76
Quantitative detection of cells expressing BlaC using droplet-based microfluidics for use in the diagnosis of tuberculosis. Biomicrofluidics (2015) 0.76
Strengthening the Tuberculosis Specimen Referral Network in Uganda: The Role of Public-Private Partnerships. J Infect Dis (2016) 0.75
Face mask sampling for the detection of Mycobacterium tuberculosis in expelled aerosols. PLoS One (2014) 0.75
Optimising Mycobacterium tuberculosis detection in resource limited settings. BMJ Open (2014) 0.75
Performance evaluation of three commercial molecular assays for the detection of Mycobacterium tuberculosis from clinical specimens in a high TB-HIV-burden setting. BMC Infect Dis (2015) 0.75
Testing Pooled Sputum with Xpert MTB/RIF for Diagnosis of Pulmonary Tuberculosis To Increase Affordability in Low-Income Countries. J Clin Microbiol (2015) 0.75
Sputum smear microscopy referral rates and turnaround time in the Tonga Islands. Public Health Action (2014) 0.75
Smear positive pulmonary tuberculosis and associated risk factors among tuberculosis suspects attending spiritual holy water sites in Northwest Ethiopia. BMC Infect Dis (2017) 0.75
Comparison of loop-mediated isothermal amplification assay and smear microscopy with culture for the diagnostic accuracy of tuberculosis. BMC Infect Dis (2017) 0.75
Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana's Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortality. BMC Infect Dis (2016) 0.75
External quality assessment of AFB smear microscopy performances and its associated factors in selected private health facilities in Addis Ababa, Ethiopia. Pan Afr Med J (2016) 0.75
It is health that is real wealth & not pieces of gold & silver. Indian J Med Res (2013) 0.75
Dilemmas with ethionamide susceptibility testing of Mycobacterium tuberculosis: A microbiologist & physician's nightmare. Indian J Med Res (2015) 0.75
Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis. Antimicrob Agents Chemother (2015) 0.75
A current overview of commercially available nucleic acid diagnostics approaches to detect and identify human gastroenteritis pathogens. Biomol Detect Quantif (2014) 0.75
Modern microbiology - a quiet revolution with many benefits. Australas Med J (2013) 0.75
Multidrug-Resistant Tuberculosis and Its Association with Adrenal Insufficiency: Assessment with the Low-Dose ACTH Stimulation Test. Int J Endocrinol (2016) 0.75
Immuno-diagnosis of Mycobacterium tuberculosis in sputum, and reduction of timelines for its positive cultures to within 3 h by pathogen-specific thymidylate kinase expression assays. BMC Res Notes (2017) 0.75
Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand. Infect Drug Resist (2017) 0.75
FluoroType MTB system for the detection of pulmonary tuberculosis. ERJ Open Res (2017) 0.75
RNomic identification and evaluation of npcTB_6715, a non-protein-coding RNA gene as a potential biomarker for the detection of Mycobacterium tuberculosis. J Cell Mol Med (2017) 0.75
Diagnostic utility of a line probe assay for multidrug resistant-TB in smear-negative pulmonary tuberculosis. PLoS One (2017) 0.75
Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med (2010) 32.89
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA (1999) 27.82
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet (2006) 21.60
A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A (2002) 13.50
Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol (2009) 12.98
The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature (1992) 11.99
Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol (1996) 10.26
Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory. J Clin Microbiol (1993) 9.76
Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet (2007) 9.71
Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis (2006) 9.35
Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet (1994) 9.20
Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis (2004) 8.41
Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med (2006) 8.39
Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol (2010) 7.90
Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med (2008) 7.47
Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis. Nat Biotechnol (1998) 6.59
Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep (2005) 6.45
Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS (2001) 5.61
Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial. Lancet (2009) 5.30
A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa. Int J Syst Bacteriol (1997) 5.28
Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB). J Clin Microbiol (1999) 5.28
Patients with active tuberculosis often have different strains in the same sputum specimen. Am J Respir Crit Care Med (2003) 5.22
Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol (2007) 5.03
The tuberculin skin test. Clin Infect Dis (1993) 4.89
Diagnosis of Mycobacterium microti infections among humans by using novel genetic markers. J Clin Microbiol (1998) 4.83
Differentiation of phylogenetically related slowly growing mycobacteria based on 16S-23S rRNA gene internal transcribed spacer sequences. J Clin Microbiol (1998) 4.82
Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. J Clin Microbiol (2001) 4.63
Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis (1999) 4.52
Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis (2008) 4.48
Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep (2009) 4.48
GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J (2008) 4.32
An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med (2006) 4.28
An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med (2010) 4.24
Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus. Am J Respir Crit Care Med (2009) 4.09
hsp65 sequencing for identification of rapidly growing mycobacteria. J Clin Microbiol (1999) 3.99
The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. Int J Tuberc Lung Dis (2004) 3.94
Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res (1998) 3.85
Diagnostic performance of amplified Mycobacterium tuberculosis direct test with cerebrospinal fluid, other nonrespiratory, and respiratory specimens. J Clin Microbiol (1996) 3.85
Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tuber Lung Dis (1995) 3.83
Direct detection of Mycobacterium tuberculosis complex in respiratory specimens by a target-amplified test system. J Clin Microbiol (1994) 3.81
Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature (2006) 3.72
Application of the Capilia TB assay for culture confirmation of Mycobacterium tuberculosis complex isolates. Int J Tuberc Lung Dis (2005) 3.62
Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol (2005) 3.61
Loop-mediated isothermal amplification for direct detection of Mycobacterium tuberculosis complex, M. avium, and M. intracellulare in sputum samples. J Clin Microbiol (2003) 3.60
Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother (2000) 3.56
Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J Clin Microbiol (2001) 3.56
Ibis T5000: a universal biosensor approach for microbiology. Nat Rev Microbiol (2008) 3.41
Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Int J Tuberc Lung Dis (1997) 3.37
Timely diagnosis of MDR-TB under program conditions: is rapid drug susceptibility testing sufficient? Int J Tuberc Lung Dis (2006) 3.34
Rapid and simple approach for identification of Mycobacterium tuberculosis complex isolates by PCR-based genomic deletion analysis. J Clin Microbiol (2002) 3.32
Sequence-based identification of Mycobacterium species using the MicroSeq 500 16S rDNA bacterial identification system. J Clin Microbiol (2000) 3.26
Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis (2007) 3.25
Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. J Clin Microbiol (2009) 3.08
Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression. PLoS One (2008) 3.07
Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. Centers for Disease Control and Prevention. MMWR Recomm Rep (1994) 2.98
Role of individual drugs in the chemotherapy of tuberculosis. Int J Tuberc Lung Dis (2000) 2.94
Identification of Mycobacterium tuberculosis and Mycobacterium avium-M. intracellulare directly from primary BACTEC cultures by using acridinium-ester-labeled DNA probes. J Clin Microbiol (1992) 2.86
Operational feasibility of using loop-mediated isothermal amplification for diagnosis of pulmonary tuberculosis in microscopy centers of developing countries. J Clin Microbiol (2007) 2.85
Genomic deletions suggest a phylogeny for the Mycobacterium tuberculosis complex. J Infect Dis (2002) 2.85
Differentiation of Mycobacterium tuberculosis complex by PCR amplification of genomic regions of difference. Int J Tuberc Lung Dis (2006) 2.78
Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol (2009) 2.75
Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med (2007) 2.71
Performance assessment of new multiplex probe assay for identification of mycobacteria. J Clin Microbiol (2001) 2.68
Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays. J Clin Microbiol (1999) 2.65
Mycobacterium tuberculosis subsp. caprae subsp. nov.: a taxonomic study of a new member of the Mycobacterium tuberculosis complex isolated from goats in Spain. Int J Syst Bacteriol (1999) 2.63
Optimizing sputum smear microscopy for the diagnosis of pulmonary tuberculosis. Expert Rev Anti Infect Ther (2007) 2.62
Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clin Chest Med (2009) 2.61
Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect Dis (2009) 2.60
Novel genetic polymorphisms that further delineate the phylogeny of the Mycobacterium tuberculosis complex. J Bacteriol (2006) 2.55
Differentiation of phylogenetically related slowly growing mycobacteria by their gyrB sequences. J Clin Microbiol (2000) 2.51
Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire. Lancet (1995) 2.42
Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay. J Clin Microbiol (2002) 2.36
Tuberculosis in seals caused by a novel member of the Mycobacterium tuberculosis complex: Mycobacterium pinnipedii sp. nov. Int J Syst Evol Microbiol (2003) 2.34
Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples. J Clin Microbiol (2003) 2.32
Molecular detection of antimicrobial resistance. Clin Microbiol Rev (2001) 2.31
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir Res (2001) 2.25
From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis. Nat Med (2007) 2.23
Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J Clin Microbiol (2001) 2.21
Evaluation of genotype MTBC assay for differentiation of clinical Mycobacterium tuberculosis complex isolates. J Clin Microbiol (2003) 2.21
Identification of mycobacteria by PCR-based sequence determination of the 32-kilodalton protein gene. J Clin Microbiol (1994) 2.20
Species identification of mycobacteria using rDNA sequencing. Methods Mol Biol (1998) 2.19
Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosis. J Clin Microbiol (2000) 2.13
Laboratory diagnostic aspects of drug resistant tuberculosis. Front Biosci (2004) 2.07
Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing. Proc Natl Acad Sci U S A (2008) 2.03
Innate immunity in tuberculosis: myths and truth. Microbes Infect (2008) 2.00
Diagnosis of mycobacterial infections by nucleic acid amplification: 18-month prospective study. J Clin Microbiol (1996) 1.94
Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex. J Clin Microbiol (2009) 1.94
Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. Int J Tuberc Lung Dis (2009) 1.92
Simultaneous infection with multiple strains of Mycobacterium tuberculosis. Clin Infect Dis (2001) 1.90
Information systems for patient follow-up and chronic management of HIV and tuberculosis: a life-saving technology in resource-poor areas. J Med Internet Res (2007) 1.89
Critical role of developing national strategic plans as a guide to strengthen laboratory health systems in resource-poor settings. Am J Clin Pathol (2009) 1.88
Multiple Mycobacterium tuberculosis strains in early cultures from patients in a high-incidence community setting. J Clin Microbiol (2002) 1.88
Sputum concentration improves diagnosis of tuberculosis in a setting with a high prevalence of HIV. Trans R Soc Trop Med Hyg (2001) 1.87
Low sensitivity of a urine LAM-ELISA in the diagnosis of pulmonary tuberculosis. BMC Infect Dis (2009) 1.80
Host factors influencing susceptibility to HIV infection and AIDS progression. Retrovirology (2007) 1.77
Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin. J Clin Microbiol (2006) 1.75
Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep (2003) 1.74
Reduction in turnaround time for laboratory diagnosis of pulmonary tuberculosis by routine use of a nucleic acid amplification test. Diagn Microbiol Infect Dis (2005) 1.73
Light-emitting diode technologies for TB diagnosis: what is on the market? Expert Rev Med Devices (2009) 1.70
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet (2009) 7.22
IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, south India. Tuber Lung Dis (1995) 3.76
Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire. AIDS (2003) 3.37
Rapid and simple approach for identification of Mycobacterium tuberculosis complex isolates by PCR-based genomic deletion analysis. J Clin Microbiol (2002) 3.32
Laboratory systems and services are critical in global health: time to end the neglect? Am J Clin Pathol (2010) 3.16
Major reduction in anti-malarial drug consumption in Senegal after nation-wide introduction of malaria rapid diagnostic tests. PLoS One (2011) 3.09
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin. Mol Cell Biol (2008) 2.85
Infant human immunodeficiency virus diagnosis in resource-limited settings: issues, technologies, and country experiences. Am J Obstet Gynecol (2007) 2.61
Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Int J Tuberc Lung Dis (2009) 2.55
Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2. J Biol Chem (2008) 2.38
Multilocus sequence analysis and rpoB sequencing of Mycobacterium abscessus (sensu lato) strains. J Clin Microbiol (2010) 2.19
Progress towards improved tuberculosis diagnostics for developing countries. Lancet (2006) 2.16
Use of an innovative, affordable, and open-source short message service-based tool to monitor malaria in remote areas of Uganda. Am J Trop Med Hyg (2011) 2.10
Laboratory diagnostic aspects of drug resistant tuberculosis. Front Biosci (2004) 2.07
The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis. Am J Respir Crit Care Med (2005) 2.06
Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. J Clin Microbiol (2009) 2.03
Phyllodes tumor of the breast. Int J Radiat Oncol Biol Phys (2007) 2.02
Comprehensive findings on clinical, bacteriological, histopathological and therapeutic aspects of cutaneous tuberculosis. Trop Med Int Health (2006) 2.00
Examining the production costs of antiretroviral drugs. AIDS (2006) 1.97
Restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, India, by use of direct-repeat probe. J Clin Microbiol (1995) 1.95
Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens. AIDS (2007) 1.94
Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function. J Exp Med (2007) 1.93
Inaccuracy of single-target sequencing for discriminating species of the Mycobacterium abscessus group. J Clin Microbiol (2009) 1.91
A multicentre study of the early bactericidal activity of anti-tuberculosis drugs. J Antimicrob Chemother (2000) 1.90
Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors. PLoS One (2010) 1.77
Isolation of tubercle bacilli from sputum samples of patients in the field studies by the cetylpyridinium chloride-sodium chloride & sodium hydroxide methods. Indian J Med Res (1995) 1.71
Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme. Tuber Lung Dis (1993) 1.69
Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, Ethiopia. Antivir Ther (2008) 1.62
Disruption of mptpB impairs the ability of Mycobacterium tuberculosis to survive in guinea pigs. Mol Microbiol (2003) 1.62
HIV/AIDS treatment and HIV vaccines for Africa. Lancet (2002) 1.58
Breast-feeding and Transmission of HIV-1. J Acquir Immune Defic Syndr (2004) 1.56
Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving first-line antiretroviral therapy. Clin Infect Dis (2012) 1.53
Short course chemotherapy for tuberculous lymphadenitis in children. BMJ (1990) 1.51
Initial drug susceptibility profile of M. tuberculosis among patients under TB programme in South India. Int J Tuberc Lung Dis (2006) 1.48
Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis. Antimicrob Agents Chemother (1996) 1.48
Population-based biochemistry, immunologic and hematological reference values for adolescents and young adults in a rural population in Western Kenya. PLoS One (2011) 1.47
Evaluating PCR, culture & histopathology in the diagnosis of female genital tuberculosis. Indian J Med Res (2011) 1.47
Update on HIV-1 diversity in Africa: a decade in review. AIDS Rev (2012) 1.44
Effect of storage of sputum specimens at room temperature on smear and culture results. Tubercle (1983) 1.43
Reference values of CD4 T lymphocytes in human immunodeficiency virus-negative adult Nigerians. Clin Diagn Lab Immunol (2005) 1.42
Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings. PLoS One (2011) 1.42
Cost-effectiveness of new WHO recommendations for prevention of mother-to-child transmission of HIV in a resource-limited setting. AIDS (2011) 1.41
World Health Organization/HIVResNet Drug Resistance Laboratory Strategy. Antivir Ther (2008) 1.36
Molecular characterization of Mycobacterium avium complex isolates giving discordant results in AccuProbe tests by PCR-restriction enzyme analysis, 16S rRNA gene sequencing, and DT1-DT6 PCR. J Clin Microbiol (1997) 1.35
Prevalence of non-tuberculous mycobacterial infections among tuberculosis suspects in Nigeria. PLoS One (2013) 1.30
Risk of development of tuberculosis in HIV-infected patients. Int J Tuberc Lung Dis (2000) 1.28
African AIDS vaccine programme for a coordinated and collaborative vaccine development effort on the continent. PLoS Med (2008) 1.23
Associations of HLA-DRB1, DQB1 and DPB1 alleles with pulmonary tuberculosis in south India. Tuber Lung Dis (1999) 1.22
Contribution of medical colleges to tuberculosis control in India under the Revised National Tuberculosis Control Programme (RNTCP): lessons learnt & challenges ahead. Indian J Med Res (2013) 1.21
Species level identification of non-tuberculous mycobacteria from South Indian BCG trial area during 1981. Tubercle (1985) 1.18
Performance of three LED-based fluorescence microscopy systems for detection of tuberculosis in Uganda. PLoS One (2010) 1.17
Isolation and Identification of Environmental Mycobacteria in the Mycobacterium bovis BCG Trial Area of South India. Appl Environ Microbiol (1994) 1.16
Multidrug-resistant tuberculosis and bedaquiline. N Engl J Med (2014) 1.13
In vitro activity of fluoroquinolones against Mycobacterium tuberculosis. J Chemother (2005) 1.13
Seroprevalence of human immunodeficiency virus (HIV) infection among tuberculosis patients in Tamil Nadu. Indian J Med Res (2003) 1.12
Evaluation of procedures for isolation of nontuberculous mycobacteria from soil and water. Appl Environ Microbiol (1994) 1.12
A quality management systems approach for CD4 testing in resource-poor settings. Am J Clin Pathol (2010) 1.12
Requirement of the mymA operon for appropriate cell wall ultrastructure and persistence of Mycobacterium tuberculosis in the spleens of guinea pigs. J Bacteriol (2005) 1.11
Evaluation of tuberculosis transmission in Tehran: using RFLP and spoligotyping methods. J Infect (2004) 1.10
Unrecognised tuberculosis in HIV-infected patients: sputum culture is a useful tool. Int J Tuberc Lung Dis (2004) 1.09
Value of bronchoalveolar lavage and gastric lavage in the diagnosis of pulmonary tuberculosis in children. Tuber Lung Dis (1995) 1.09
Ensuring the quality of HIV rapid testing in resource-poor countries using a systematic approach to training. Am J Clin Pathol (2010) 1.09
Population dynamics of tuberculous Bacilli in Cameroon as assessed by spoligotyping. J Clin Microbiol (2012) 1.09
Generation of a consensus sequence from prevalent and incident HIV-1 infections in West Africa to guide AIDS vaccine development. Virology (2002) 1.08
Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria. BMC Infect Dis (2013) 1.08
Association of pulmonary tuberculosis and HLA in south India. Tubercle (1991) 1.07
Scale-up of HIV Viral Load Monitoring - Seven Sub-Saharan African Countries. MMWR Morb Mortal Wkly Rep (2015) 1.05
The centrality of laboratory services in the HIV treatment and prevention cascade: The need for effective linkages and referrals in resource-limited settings. AIDS Patient Care STDS (2014) 1.03
Moxifloxacin and gatifloxacin in an acid model of persistent Mycobacterium tuberculosis. J Chemother (2006) 1.02
Malaria rapid diagnostic test transport and storage conditions in Burkina Faso, Senegal, Ethiopia and the Philippines. Malar J (2012) 1.01
Timing and determinants of mother-to-child transmission of HIV in Nigeria. Int J Gynaecol Obstet (2009) 1.00
A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis (2003) 0.99
Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD. Am J Kidney Dis (2006) 0.99
Global evolutionary trend of the prevalence of primary glomerulonephritis over the past three decades. Nephron Clin Pract (2010) 0.99
Five year results of a 3-month and two 5-month regimens for the treatment of sputum-positive pulmonary tuberculosis in south India. Tubercle (1990) 0.98
Suppression of TGF-beta signaling by phospholipase D. Cell Cycle (2007) 0.98
Simultaneous detection of major drug resistance mutations in the protease and reverse transcriptase genes for HIV-1 subtype C by use of a multiplex allele-specific assay. J Clin Microbiol (2013) 0.98
Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma. Am J Ophthalmol (2013) 0.98
Effects of four different meal types on the population pharmacokinetics of single-dose rifapentine in healthy male volunteers. Antimicrob Agents Chemother (2010) 0.97
Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence. Ann Surg Oncol (2010) 0.97
A direct rifampicin sensitivity test for tubercle bacilli. Indian J Med Res (1995) 0.97
Social determinants of mixed feeding behavior among HIV-infected mothers in Jos, Nigeria. AIDS Care (2009) 0.96
Trypanosoma brucei gambiense trypanosomiasis in Terego county, northern Uganda, 1996: a lot quality assurance sampling survey. Am J Trop Med Hyg (2004) 0.96
Anti-tuberculosis drug resistance in patients with HIV and tuberculosis in South India. Int J Tuberc Lung Dis (2005) 0.96
Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells. Cancer Lett (2010) 0.95
Surveillance of anti-tuberculosis drug resistance in Ernakulam District, Kerala State, South India. Int J Tuberc Lung Dis (2007) 0.95
Biological properties of Salmonella typhi used for further categorising major phage types. Indian J Med Res (1979) 0.94
HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria. AIDS Care (2010) 0.93
Evaluation of microplate Alamar blue assay for drug susceptibility testing of Mycobacterium avium complex isolates. Diagn Microbiol Infect Dis (2004) 0.93
Conventional and molecular epidemiology of tuberculosis in homeless patients in Budapest, Hungary. J Clin Microbiol (2004) 0.92
Evaluation of a dried blood and plasma collection device, SampleTanker(®), for HIV type 1 drug resistance genotyping in patients receiving antiretroviral therapy. AIDS Res Hum Retroviruses (2013) 0.92
Trichosporon Beigelli Infection in Tamilnadu. Indian J Dermatol Venereol Leprol (2017) 0.91
Mycetomas in Madras. Sabouraudia (1977) 0.90
Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens. Trop Med Int Health (2005) 0.89
A comprehensive evaluation of the proficiency testing program for the HIV-1 BED incidence assay. J Clin Microbiol (2011) 0.89
Analysis of fluoroquinolone resistance in clinical isolates of Mycobacterium tuberculosis from India. J Chemother (2007) 0.89
Clinical benefits, costs, and cost-effectiveness of neonatal intensive care in Mexico. PLoS Med (2010) 0.89
Increased expression of Mycobacterium tuberculosis 19 kDa lipoprotein obliterates the protective efficacy of BCG by polarizing host immune responses to the Th2 subtype. Scand J Immunol (2005) 0.89